We evaluated the impact of several anthropometric parameters on serum peak TSH levels after standard two-dose of recombinant human thyrotropin(rhTSH) injection and assessed the usefulness of repeated measurement of TSH and thyroglobulin (Tg) levels at 24 and 72 hrs after rhTSH injection (Day 3 and 5) to confirm stimulated Tg level.
Body size and renal function influence serum peak TSH levels after rhTSH injection. On this basis, more personalized rhTSH dosage could be used in clinical practice, adjusted for BSA and GFR. The repeated measurement on Day 5 seemed to be necessary to assess stimulated Tg level.
We retrospectively reviewed 270 differentiated thyroid carcinoma patients who underwent rhTSH stimulation for radioactive iodine therapy in our clinic between 2013 and 2014. Serum TSH and Tg level were measured twice Day 3 and 5 after rhTSH injection. Univariate and multivariate analyses were performed to elucidate predictive factors of the peak TSH level. The repetitive values of Tg was compared by two-tailed paired T-test.
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